ECMO vs LVAD: Which Supports a Failing Heart Better?

ECMO and LVAD are both mechanical circulatory support devices, but they serve fundamentally different clinical purposes. ECMO provides short-term biventricular and pulmonary support in acute, life-threatening failure, with survival rates of 30 to 70 percent depending on indication and centre volume. LVAD provides longer-term left ventricular support in chronic advanced heart failure, with one-year survival above 80 percent on current continuous-flow devices. The choice is determined by acuity, duration of support needed, right ventricular function, and the intended clinical goal.

According to Dr. Vishal Khullar, a Cardiac Surgeon in Mumbai, “ECMO buys time in a crisis. LVAD changes a patient’s life over months and years. Choosing between them isn’t about which is better overall. It’s about which one fits the clinical situation in front of you.”

Two devices. Very different roles. Here is the clinical split.

Duration of support: ECMO is a short-term bridge. Days in most cases, occasionally weeks. It’s not designed for chronic use and complications accumulate with time. LVAD is built for the long term. Patients go home, return to activity, and stay on device support for months or years while waiting for a transplant or as permanent therapy.

Mobility and quality of life: ECMO keeps the patient in the ICU, bed-bound, dependent on a large external machine. LVAD patients carry a controller and battery pack. They walk. They leave hospital. That gap in quality of life shapes which device is appropriate at which stage.

Right ventricular function: LVAD unloads the left ventricle but adds volume to the right. If the right ventricle is already weak, LVAD implantation can precipitate right heart failure. ECMO handles both sides and avoids that risk in the acute phase.

Surgical burden: ECMO requires cannulation, not open surgery. LVAD implantation is a major operation. For a patient too unstable for surgery, ECMO is the only option. Once stabilised, LVAD becomes the next conversation.

For what daily life looks like on device support, read our blog on LVAD care.

Dr. Vishal Khullar is the Director of Cardiovascular and Thoracic Surgery, Heart and Lung Transplant at Fortis Hospital Mulund and Fortis S.L. Raheja Hospital, Mumbai. Over 30 years in the field. Training at Cleveland Clinic and Mayo Clinic in the USA. More than 7,000 completed procedures, including direct experience in ECMO management, LVAD implantation, and mechanical circulatory support decisions in complex heart failure cases.

His mechanical support assessments cover the full spectrum, acute ECMO in cardiogenic shock through to LVAD implantation and transplant listing. Patients and families get a clear clinical picture of which device fits their situation and why. Call +91 99870 77880 to book your consultation.

1. NCBI StatPearls (NIH) – Extracorporeal Membrane Oxygenation in Adults 
2. PubMed – LVAD Therapy in Advanced Heart Failure